Quest Diagnostics Inc (DGX)
122.97
-2.00 -1.60%
NYSE
Oct 29, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 8.361B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 8.09 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 1.105B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 43.29% |
| Profit Margin (Quarterly) | 20.39% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 1.80% |
| Price and Valuation | |
| Market Cap | 16.57B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 2.000 |
| PE Ratio | 15.20 |
| Price to Book Value | 2.589 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.7145 |
| Free Cash Flow (Quarterly) | 771.00M |
| Return on Equity | Upgrade |
View All DGX News
News
-
WireHeadlineTime (ET)
-
Yahoo10/28 19:30
-
Yahoo10/28 10:58
-
Yahoo10/28 10:01
-
SA Breaking News10/28 05:15
-
MT Newswires10/27 12:13
-
Yahoo10/27 11:09
-
PR Newswire10/27 07:30
-
Yahoo10/26 22:05
-
Yahoo10/24 10:04
-
Yahoo10/22 16:34
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 01/29/2021 | Earnings | Quest Diagnostics Inc Fourth Quarter Earnings for 2020 Release |
| 01/29/2021 08:30 EST | Misc | Quest Diagnostics Inc Fourth Quarter Earnings Conference Call for 2020 |
| 10/22/2020 08:30 EDT | Misc | Quest Diagnostics Inc Third Quarter Earnings Conference Call for 2020 |
| 10/22/2020 | Earnings | Quest Diagnostics Inc Third Quarter Earnings Result for 2020 |
| 10/05/2020 | Dividends | Amount: 0.56, Declared Date: Aug 18 2020, Pay Date: Oct 21 2020 |
| 07/23/2020 08:30 EDT | Misc | Quest Diagnostics Inc Second Quarter Earnings Conference Call for 2020 |
| 07/23/2020 | Earnings | Quest Diagnostics Inc Second Quarter Earnings Result for 2020 |
| 07/07/2020 | Dividends | Amount: 0.56, Declared Date: May 18 2020, Pay Date: Jul 22 2020 |
| 05/19/2020 | Misc | Quest Diagnostics Inc Annual General Meeting for 2019 |
| 04/22/2020 08:30 EDT | Misc | Quest Diagnostics Inc First Quarter Earnings Conference Call for 2020 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.questdiagnostics.com
- Investor Relations URL: http://ir.questdiagnostics.com/phoenix.zhtml?c=82068&p=irol-irhome
- HQ State/Province: New Jersey
- Sector: Healthcare
- Industry: Diagnostics & Research
- Equity Style: Mid Cap/Value
- Next Earnings Release: Jan. 29, 2021
- Last Earnings Release: Oct. 22, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Oct. 05, 2020
- Description: Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of 2,000 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 122.97 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| FMIHX | FMI Large Cap Investor | 4.97% |
| IHF | iShares US Healthcare Providers ETF | 3.51% |
| GLO | Clough Global Opportunities | 2.25% |
| NYVBX | Davis NY Venture B | 2.20% |
| SMVFX | Virtus Ceredex Mid-Cap Value Equity C | 2.19% |
| GQLFX | GMO Quality V | 2.04% |
| RYH | Invesco S&P 500® Equal Wt Hlth Care ETF | 1.79% |
| VEVCX | Victory Sycamore Established Value C | 1.75% |
| ZUH.TO | BMO Eq Wght US HlthCare Hdgd to CAD ETF | 1.74% |
| AMVGX | American Century Mid Cap Value R5 | 1.67% |
| USA | Liberty All-Star Equity | 0.93% |
| FVD | First Trust Value Line® Dividend ETF | 0.56% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- DGX Tweets Stocktwits
Advertisement
